Prognosis Related to Metastatic Burden Measured by ¹⁸F-Fluorocholine PET/CT in Castration-Resistant Prostate Cancer.
about
Positron emission tomography in imaging evaluation of staging, restaging, treatment response, and prognosis in prostate cancer.Prognostic Utility of PET in Prostate Cancer.Prediction of PSA Progression in Castration-Resistant Prostate Cancer Based on Treatment-Associated Change in Tumor Burden Quantified by 18F-Fluorocholine PET/CTPET and PET/CT with radiolabeled choline in prostate cancer: a critical reappraisal of 20 years of clinical studies.Therapy assessment in prostate cancer using choline and PSMA PET/CT.Multimodality imaging using proton magnetic resonance spectroscopic imaging and 18F-fluorodeoxyglucose-positron emission tomography in local prostate cancer.Changes in Skeletal Tumor Activity on (18)F-choline PET/CT in Patients Receiving (223)Radium Radionuclide Therapy for Metastatic Prostate Cancer.Circulating androgen receptor combined with 18F-fluorocholine PET/CT metabolic activity and outcome to androgen receptor signalling-directed therapies in castration-resistant prostate cancer.Prognostic value of 18F-choline PET/CT metabolic parameters in patients with metastatic castration-resistant prostate cancer treated with abiraterone or enzalutamide.(11)C-Choline PET/CT in castration-resistant prostate cancer patients treated with docetaxel.Fluorine-18-fluorocholine PET/CT parameters predictive for hematological toxicity to radium-223 therapy in castrate-resistant prostate cancer patients with bone metastases: a pilot study.Positron emission tomography in prostate cancer: An update on state of the art
P2860
Q33625371-9948BDCD-8B50-4FFB-B89E-7312FF8DA867Q35244433-6D4D944D-52D7-4F78-B7FD-68C3A7C100BCQ37496697-79B79608-0C14-451F-8D08-44305087A90FQ39242140-9BA103B2-33C7-4F77-BCCA-0A5DD5775BABQ39328036-3698354F-28A6-4369-A535-38BB6B9452BDQ42371983-A1952B32-3191-4198-94A4-557A6688EBEDQ42530668-82BA329A-9175-4177-8C7F-5C537876537EQ44453209-A789F252-5320-42E2-81C4-4F261914D380Q47645575-4252562D-42B6-4C18-BE2A-1F24A2E9E98FQ48139886-742EE7C9-1ED5-49A8-9208-803A9EBA2931Q55603215-1FD900B5-BF44-4F2E-B088-04DA8CD1CA02Q57110351-9E9A293B-FD44-4994-BBAD-EE54ECDF89B6
P2860
Prognosis Related to Metastatic Burden Measured by ¹⁸F-Fluorocholine PET/CT in Castration-Resistant Prostate Cancer.
description
2014 nî lūn-bûn
@nan
2014年の論文
@ja
2014年論文
@yue
2014年論文
@zh-hant
2014年論文
@zh-hk
2014年論文
@zh-mo
2014年論文
@zh-tw
2014年论文
@wuu
2014年论文
@zh
2014年论文
@zh-cn
name
Prognosis Related to Metastati ...... ion-Resistant Prostate Cancer.
@ast
Prognosis Related to Metastati ...... ion-Resistant Prostate Cancer.
@en
type
label
Prognosis Related to Metastati ...... ion-Resistant Prostate Cancer.
@ast
Prognosis Related to Metastati ...... ion-Resistant Prostate Cancer.
@en
prefLabel
Prognosis Related to Metastati ...... ion-Resistant Prostate Cancer.
@ast
Prognosis Related to Metastati ...... ion-Resistant Prostate Cancer.
@en
P2093
P2860
P1476
Prognosis Related to Metastati ...... tion-Resistant Prostate Cancer
@en
P2093
Alex Watanabe
Kathleen Kromer-Baker
Marc N Coel
P2860
P304
P356
10.2967/JNUMED.113.135194
P407
P50
P577
2014-03-27T00:00:00Z